Statistics from Altmetric.com
Osteoarthritis (OA) is one of the most frequent musculoskeletal diseases worldwide and is associated with a high burden of disease causing disability and considerable socioeconomic costs. In the USA, 200 000 patients undergo total hip replacement surgery annually as a consequence of joint failure owing to severe OA.1 The pharmacotherapy of advanced OA is limited to symptomatic treatment to obtain pain relief. To date, no drugs are available which allow rebuilding of damaged cartilage,2 and this may not change during the next few years, reinforcing the relevance of targeted interventions in early OA or even before the development of symptoms. As a consequence, clinicians have the challenging task of identifying those …
Funding This study was supported by the ANKYLOSIS project of the Bundesministerium für Bildung und Forschung (BMBF), the ADIPOA project of the European Union and the Pustertaler Verein zur Prävention von Herzund Hirngefässerkrankungen.
Competing interests None.
Patient consent Obtained.
Ethics approval This study was conducted with the approval of the Medical University of Innsbruck.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.